NovoCure Raises FY2026 Sales Guidance from $710.000M-$725.000M to $736.000M-$743.000M vs $725.814M Est
Benzinga Newsdesk 2 days ago
NewsGuidance
NovoCure (NASDAQ:NVCR) raises FY2026 sales outlook from $710.000 million-$725.000 million to $736.000 million-$743.000 million vs $725.814 million estimate.
NovoCure (NASDAQ:NVCR) raises FY2026 sales outlook from $710.000 million-$725.000 million to $736.000 million-$743.000 million vs $725.814 million estimate.